News

TriSalus' tri-pronged approach may offer new hope to pancreatic and liver cancer patients says CEO

News

2020-08-03
TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales

2020-02-12
TriSalus Life Sciences and Roger Williams Medical Center Announce Initiation of Phase 1 Clinical Trial for a Novel Delivery Technology That Can Enhance Drug Delivery into Pancreatic Tumors

2020-02-10
TriSalus Life Sciences CEO Mary Szela to Speak on Panel at 2020 BIO CEO & Investor Conference

2020-01-13
TriSalus launches TriNav Infusion System

2019-06-27
TriSalus Life Sciences Forms World-Class Scientific Advisory Board to Accelerate Advancement of Strategy to Deliver Therapeutics to Solid Tumors